Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vitro Biopharma

Volume:- -
Turnover:- -
Market Cap:- -
PE:- -
High:- -
Open:- -
Low:- -
Close:- -
Loading ...
Mar 20, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Sep 16, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 11, 2024

Correspondence

Form CORRESP - Correspondence
Sep 11, 2024

Correspondence

Form CORRESP - Correspondence
Sep 05, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 30, 2024

Correspondence

Form CORRESP - Correspondence
Aug 24, 2024

Correspondence

Form CORRESP - Correspondence
Aug 23, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 09, 2024

Correspondence

Form CORRESP - Correspondence
Aug 08, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 02, 2024

Correspondence

Form CORRESP - Correspondence
Jul 01, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 17, 2024

Major Issues Report

Form 8-K - Current report
Apr 17, 2024

Major Issues Report

Form 8-K - Current report
Mar 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 03, 2024

Correspondence

Form CORRESP - Correspondence